Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
615 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02172846 | Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer | completed | Phase 1 | 23 | Washington University School of MedicineOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT02510950 | Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma | terminated | Phase 1 | 1 | Washington University School of MedicineOTHER | 1 | Nov 17, 2017 |
| clinicaltrials |
| NCT00540007 | Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma | completed | Phase 2 | 80 | Washington University School of MedicineOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00682786 | Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma | completed | Phase 2 | 135 | Washington University School of MedicineOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT03007771 | Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Oct 6, 2017 | clinicaltrials |
| NCT02658708 | Bright Light on Fatigue in Women Being Treated for Breast Cancer | completed | Phase 1 | 19 | Washington University School of MedicineOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT00594477 | Intensity Modulated Radiotherapy for Breast Cancer(IMRT) | completed | Phase 1 | 100 | Washington University School of MedicineOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT01410006 | Neurofibromatosis Type 1 Patient Registry(NPRI) | completed | — | 2,391 | Washington University School of MedicineOTHER | 1 | Jul 25, 2017 | clinicaltrials |
| NCT02098109 | Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma | completed | Phase 2 | 100 | Washington University School of MedicineOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT00241358 | Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies | completed | Phase 1 / Phase 2 | 92 | Washington University School of MedicineOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT01158118 | Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors | completed | Phase 2 | 48 | Washington University School of MedicineOTHER | 1 | Jun 5, 2017 | clinicaltrials |
| NCT00914849 | Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies | completed | Phase 2 | 68 | Washington University School of MedicineOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT01359410 | Reinforced Staple Line on Leak Rate in Distal Pancreatectomy | terminated | N/A | 112 | Washington University School of MedicineOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT01707836 | Neurofibromatosis Type 1 Brain Tumor Genetic Risk | completed | — | 176 | Washington University School of MedicineOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02564536 | Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | May 8, 2017 | clinicaltrials |
| NCT02204137 | Falls Risk Questionnaire in Older Adults With Cancer | completed | — | 21 | Washington University School of MedicineOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT02277093 | Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer | terminated | Phase 2 | 11 | Washington University School of MedicineOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT01722162 | Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer | completed | Phase 2 | 47 | Washington University School of MedicineOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT01060033 | MRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer(MRI) | completed | N/A | 9 | Washington University School of MedicineOTHER | 1 | Apr 14, 2017 | clinicaltrials |
| NCT02618447 | 4D Phase Contrast MR: Hypertrophy in Liver Cancer | terminated | N/A | 10 | Washington University School of MedicineOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT00906945 | Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | completed | Phase 1 / Phase 2 | 39 | Washington University School of MedicineOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT01000285 | EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma(ATLL) | completed | Phase 1 / Phase 2 | 18 | Washington University School of MedicineOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT00263211 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | terminated | Phase 2 | 48 | Washington University School of MedicineOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00671437 | Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer(SCCHN) | completed | Phase 2 | 42 | Washington University School of MedicineOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT02089386 | Tamoxifen to Treat Barrett's Metaplasia | terminated | Early Phase 1 | 7 | Washington University School of MedicineOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT00733824 | Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma | completed | Phase 1 / Phase 2 | 61 | Washington University School of MedicineOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT01060007 | Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer | completed | Phase 2 | 80 | Washington University School of MedicineOTHER | 1 | Mar 8, 2017 | clinicaltrials |
| NCT00703625 | Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies | completed | Phase 1 | 26 | Washington University School of MedicineOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT02311556 | Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging | completed | Phase 1 | 23 | Washington University School of MedicineOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT01668134 | Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma | completed | Phase 1 | 28 | Washington University School of MedicineOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT02331381 | Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device | terminated | Phase 1 | 15 | Washington University School of MedicineOTHER | 1 | Feb 20, 2017 | clinicaltrials |
| NCT02976441 | Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Feb 20, 2017 | clinicaltrials |
| NCT00802880 | Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma | completed | Phase 2 | 80 | Washington University School of MedicineOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01339442 | BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer | completed | Phase 1 | 31 | Washington University School of MedicineOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00907140 | Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study | completed | N/A | 25 | Washington University School of MedicineOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT02355054 | Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study | approved for marketing | — | — | Washington University School of MedicineOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT01308944 | Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients | completed | Phase 1 | 24 | Washington University School of MedicineOTHER | 1 | Jan 12, 2017 | clinicaltrials |
| NCT02723370 | Implementation of Evidence Based Practices for Colonoscopy: The Strategies to Improve Colonoscopy Study(STIC) | completed | N/A | 46,184 | Washington University School of MedicineOTHER | 0 | Jan 10, 2017 | clinicaltrials |
| NCT01167192 | Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer | terminated | Phase 2 | 10 | Washington University School of MedicineOTHER | 1 | Dec 30, 2016 | clinicaltrials |
| NCT01553851 | GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer | completed | Phase 2 | 20 | Washington University School of MedicineOTHER | 1 | Dec 26, 2016 | clinicaltrials |
| NCT00537823 | Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | terminated | Phase 2 | 9 | Washington University School of MedicineOTHER | 1 | Dec 20, 2016 | clinicaltrials |
| NCT00352755 | A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis | terminated | Phase 2 | 18 | Washington University School of MedicineOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00921310 | Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 12 | Washington University School of MedicineOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00352690 | A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer | terminated | Phase 2 | 10 | Washington University School of MedicineOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT00384956 | A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes | completed | Phase 2 | 25 | Washington University School of MedicineOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT00512252 | AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia(AMD3100+MEC) | completed | Phase 1 / Phase 2 | 52 | Washington University School of MedicineOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT02264886 | Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies | completed | Phase 1 | 30 | Washington University School of MedicineOTHER | 1 | Dec 9, 2016 | clinicaltrials |
| NCT02112162 | Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery | terminated | Phase 1 | 2 | Washington University School of MedicineOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT01555853 | Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma | terminated | Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02371031 | FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas | terminated | Phase 1 | 11 | Washington University School of MedicineOTHER | 1 | Nov 30, 2016 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials